Search Results 201-210 of 16259 for monoclonal antibody

1. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...

2. Preventing, treating COVID-19 infection - Mayo Clinic News Network

   1 is monoclonal antibodies. These are laboratory-made proteins that mimic the immune system to fight off the virus by blocking the entry of the virus into ...

3. Autoimmune encephalitis: Paving the way to better outcomes - Mayo Clinic

   Mayo Clinic is exploring the potential benefit of inebilizumab, a monoclonal antibody recently approved for the treatment of neuromyelitis optica spectrum ...

4. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability ... antibody. Measurable disease of multiple myeloma as defined by at ...

5. PCSK9 inhibition: A game changer in cholesterol management - Mayo Clinic

   Binding of circulating PCSK9 by parenteral monoclonal antibodies results in augmented recirculation of the LDL receptor to the hepatocyte surface and ...

6. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies ... Patients who have a history of a severe hypersensitivity reaction to monoclonal antibody or pembrolizumab (MK-3475) ...

7. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Monoclonal antibodies, such as rituximab, can block cancer growth in difference ways. Some block the ability of cancer cells to grow and spread. Others find ...

8. A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14) - Mayo Clinic

   The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination with ...

9. Translational Neuro-Oncology: Jann N. Sarkaria - Research Projects

   ADC biology. One promising novel therapeutic approach uses antibody-drug conjugates (ADC). ADCs combine monoclonal antibodies and cytotoxic payloads to target ...

10. Hematology - Clinical trials

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...